Related Experiment Video
Updated: Oct 25, 2025

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Hyperbilirubinemia in the Term Infant: Re-evaluating What We Think We Know
Cathy Hammerman1, Michael Kaplan2
1Department of Neonatology, Shaare Zedek Medical Center; The Faculty of Medicine of the Hebrew University, Jerusalem, Israel.
Abstract:
This article attempts to highlight contemporary issues relating to term neonatal hyperbilirubinemia and to focus attention on controversial issues and concepts with the potential to effect change in clinical approach. On the one hand, the focus is bilirubin neurotoxicity, which is now known to encompass a wide, diverse spectrum of features. The various aspects of this spectrum are outlined and defined. On the other hand, bilirubin also possesses antioxidant properties. As such, mild hyperbilirubinemia is suggested as actually offering the neonate some protective advantage.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Rh Blood Group
Pharmacokinetics in Pediatric Patients: Drug Distribution

